跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Clorazepate Dipotassium 15 mg Tablets Bottle - TGA Drug Approval Details
Approvals
/
TGA
/
Clorazepate Dipotassium 15 mg Tablets Bottle
Approved
STANDARD
Clorazepate Dipotassium 15 mg Tablets Bottle
Alphapharm Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
Dec 9, 2025
Approval ID
094a251af3d965b0
Company
Alphapharm Pty Ltd
Type
Standard
Approval Details
Approval Id
094a251af3d965b0
Product Name
Clorazepate Dipotassium 15 mg Tablets Bottle
Artg Id
368538
Artg Name
Clorazepate Dipotassium 15 mg Tablets Bottle
Sponsor
Alphapharm Pty Ltd
Company Detail Path
/organization/alphapharm-pty-ltd
Artg Date
2021-06-08
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
LIE
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
Dec 9, 2025
Approval ID
094a251af3d965b0
Type
Standard
Back to TGA Approvals
